Patrick Frost, PhD

Patrick Frost, PhD

Feb 10, 2016

Group 6 Copy 71
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

An initial exploration of in-situ underwater genetic sequencing

Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

Have cryptic cervid pathogens moved into the northeastern US while we weren’t looking?

Due to their cryptic nature, very little is known about the northward-creeping and vector-borne pathogens...

How do post-industrial landscapes affect American Woodcock breeding success?

I study American Woodcock breeding success in post-industrial habitat to see if human altered habitat can...

Backer Badge Funded